Regeneron Pharmaceuticals, Inc. (REGN)
745.77
-0.84
(-0.11%)
USD |
NASDAQ |
Mar 13, 16:00
750.00
+4.23
(+0.57%)
Pre-Market: 08:37
Regeneron Pharmaceuticals Profit Margin (Quarterly) : 21.74% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 13.47% |
| Johnson & Johnson | 20.83% |
| Eli Lilly & Co. | 34.40% |
| Merck & Co., Inc. | 18.15% |
| Pfizer Inc. | -9.34% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.93% |
| Return on Assets | 11.59% |
| Return on Invested Capital | 13.66% |
| Gross Profit Margin (Quarterly) | 81.22% |
| Operating Margin (Quarterly) | 23.13% |
| Return on Net Operating Assets | 29.72% |